J&J Expected To Beat Rivals With Release Of Drug-Coated Stents

03/18/2002 | CNN · Yahoo/Reuters

Johnson & Johnson yesterday unveiled new data that show its antibiotic-coated stent prevents heart arteries from reclogging after 12 months of implantation. The company's Cordis unit is expected to market the device by 2003, six months before its rivals release their solutions. Doctors say the device will help patients needing a repeat procedure.

View Full Article in:

CNN · Yahoo/Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA